Pediatric Vaccines Market Size, Share & Trends Analysis Report By Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Others), By Application (Infectious Disease, Cancer, Allergy, Pneumococcal Diseases, Influenza, Measles, Mumps, and Rubella (MMR), Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Pediatric Vaccines Market Size Analysis
    1. Introduction
    2. Pediatric Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Pediatric Vaccines Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Live Attenuated Vaccines
      2. Inactivated Vaccines
      3. Subunit Vaccines
      4. Toxoid Vaccines
      5. Conjugate Vaccines
      6. Others
    4. Pediatric Vaccines Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Infectious Disease
      2. Cancer
      3. Allergy
      4. Pneumococcal Diseases
      5. Influenza
      6. Measles, Mumps, and Rubella (MMR)
      7. Others
  7. North America Pediatric Vaccines Market Size Analysis
    1. Introduction
    2. Pediatric Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Pediatric Vaccines Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Live Attenuated Vaccines
      2. Inactivated Vaccines
      3. Subunit Vaccines
      4. Toxoid Vaccines
      5. Conjugate Vaccines
      6. Others
    4. Pediatric Vaccines Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Infectious Disease
      2. Cancer
      3. Allergy
      4. Pneumococcal Diseases
      5. Influenza
      6. Measles, Mumps, and Rubella (MMR)
      7. Others
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
  8. Europe Pediatric Vaccines Market Size Analysis
    1. Introduction
    2. Pediatric Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Pediatric Vaccines Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Live Attenuated Vaccines
      2. Inactivated Vaccines
      3. Subunit Vaccines
      4. Toxoid Vaccines
      5. Conjugate Vaccines
      6. Others
    4. Pediatric Vaccines Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Infectious Disease
      2. Cancer
      3. Allergy
      4. Pneumococcal Diseases
      5. Influenza
      6. Measles, Mumps, and Rubella (MMR)
      7. Others
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    7. France
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
  9. APAC Pediatric Vaccines Market Size Analysis
    1. Introduction
    2. Pediatric Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Pediatric Vaccines Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Live Attenuated Vaccines
      2. Inactivated Vaccines
      3. Subunit Vaccines
      4. Toxoid Vaccines
      5. Conjugate Vaccines
      6. Others
    4. Pediatric Vaccines Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Infectious Disease
      2. Cancer
      3. Allergy
      4. Pneumococcal Diseases
      5. Influenza
      6. Measles, Mumps, and Rubella (MMR)
      7. Others
    5. China
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    8. India
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
  10. Middle East and Africa Pediatric Vaccines Market Size Analysis
    1. Introduction
    2. Pediatric Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Pediatric Vaccines Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Live Attenuated Vaccines
      2. Inactivated Vaccines
      3. Subunit Vaccines
      4. Toxoid Vaccines
      5. Conjugate Vaccines
      6. Others
    4. Pediatric Vaccines Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Infectious Disease
      2. Cancer
      3. Allergy
      4. Pneumococcal Diseases
      5. Influenza
      6. Measles, Mumps, and Rubella (MMR)
      7. Others
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
  11. LATAM Pediatric Vaccines Market Size Analysis
    1. Introduction
    2. Pediatric Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Pediatric Vaccines Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Live Attenuated Vaccines
      2. Inactivated Vaccines
      3. Subunit Vaccines
      4. Toxoid Vaccines
      5. Conjugate Vaccines
      6. Others
    4. Pediatric Vaccines Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Infectious Disease
      2. Cancer
      3. Allergy
      4. Pneumococcal Diseases
      5. Influenza
      6. Measles, Mumps, and Rubella (MMR)
      7. Others
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Live Attenuated Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. Toxoid Vaccines
        5. Conjugate Vaccines
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Infectious Disease
        2. Cancer
        3. Allergy
        4. Pneumococcal Diseases
        5. Influenza
        6. Measles, Mumps, and Rubella (MMR)
        7. Others
  12. Competitive Landscape
    1. Pediatric Vaccines Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Pfizer Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Sanofi
    3. GSK plc
    4. Merck & Co., Inc.
    5. AstraZeneca
    6. Johnson & Johnson Services Inc.
    7. Moderna, Inc.
    8. BioNTech SE
    9. Novavax, Inc.
    10. Valneva SE
    11. Daiichi Sankyo Company Limited
    12. Takeda Pharmaceutical Company Limited
    13. Serum Institute of India Pvt. Ltd.
    14. Bharat Biotech
    15. Indian Immunologicals Ltd.
    16. Zydus Group
    17. Sinovac
    18. Biological E Limited
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

List of Tables

Table 1: Global Pediatric Vaccines Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 3: Global Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 4: Global Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 5: North America Pediatric Vaccines Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 6: North America Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 7: North America Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 8: North America Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 9: U.S. Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 10: U.S. Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 11: U.S. Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 12: Canada Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 13: Canada Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 14: Canada Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 15: Europe Pediatric Vaccines Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 16: Europe Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 17: Europe Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 18: Europe Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 19: U.K. Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 20: U.K. Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 21: U.K. Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 22: Germany Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 23: Germany Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 24: Germany Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 25: France Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 26: France Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 27: France Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 28: Spain Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 29: Spain Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 30: Spain Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 31: Italy Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 32: Italy Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 33: Italy Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 34: Russia Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 35: Russia Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 36: Russia Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 37: Nordic Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 38: Nordic Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 39: Nordic Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 40: Benelux Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 41: Benelux Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 42: Benelux Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 43: Rest of Europe Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 44: Rest of Europe Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 45: Rest of Europe Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 46: APAC Pediatric Vaccines Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 47: APAC Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 48: APAC Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 49: APAC Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 50: China Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 51: China Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 52: China Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 53: Korea Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 54: Korea Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 55: Korea Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 56: Japan Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 57: Japan Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 58: Japan Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 59: India Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 60: India Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 61: India Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 62: Australia Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 63: Australia Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 64: Australia Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 65: Taiwan Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 66: Taiwan Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 67: Taiwan Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 68: South East Asia Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 69: South East Asia Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 70: South East Asia Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 71: Rest of Asia-Pacific Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 72: Rest of Asia-Pacific Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 73: Rest of Asia-Pacific Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 74: Middle East and Africa Pediatric Vaccines Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 75: Middle East and Africa Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 76: Middle East and Africa Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 77: Middle East and Africa Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 78: UAE Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 79: UAE Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 80: UAE Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 81: Turkey Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 82: Turkey Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 83: Turkey Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 84: Saudi Arabia Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 85: Saudi Arabia Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 86: Saudi Arabia Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 87: South Africa Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 88: South Africa Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 89: South Africa Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 90: Egypt Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 91: Egypt Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 92: Egypt Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 93: Nigeria Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 94: Nigeria Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 95: Nigeria Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 96: Rest of MEA Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 97: Rest of MEA Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 98: Rest of MEA Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 99: LATAM Pediatric Vaccines Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 100: LATAM Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 101: LATAM Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 102: LATAM Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 103: Brazil Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 104: Brazil Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 105: Brazil Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 106: Mexico Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 107: Mexico Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 108: Mexico Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 109: Argentina Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 110: Argentina Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 111: Argentina Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 112: Chile Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 113: Chile Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 114: Chile Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 115: Colombia Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 116: Colombia Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 117: Colombia Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 118: Rest of LATAM Pediatric Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 119: Rest of LATAM Pediatric Vaccines Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 120: Rest of LATAM Pediatric Vaccines Market Size and Forecast By Application - 2022-2034 (USD Billion)

We are featured on: